ArticleFrontiers in immunology2025
Transcriptomic profiling reveals distinct molecular signatures among lesion types in hidradenitis suppurativa.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multispecies Transcriptomics of Mammalian Skin Reveals Conserved and Divergent Regulatory Features.International journal of molecular sciences · 2026Article
- Bimekizumab and progressive pulmonary fibrosis in severe psoriasis: a case report.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hidradenitis suppurativa is a painful inflammatory disease characterised by diverse cutaneous lesions that exhibit distinct clinical morphologies. The study aimed to examine the transcriptome of the various hidradenitis suppurativa lesion types. Methods: Transcriptomic analyses were performed using bulk RNA sequencing to examine the various lesion types, including draining tunnels, inflammatory nodules, non-draining tunnels, non-lesional skin from patients with hidradenitis suppurativa and normal skin from healthy individuals. Results/discussion: Principal component and differential expression analyses revealed that these different lesion types exhibit distinct expression profiles while sharing common transcriptional features. Enrichment analysis of exclusively differentially expressed genes for each lesion type showed increased antigen presentation and cytotoxic T cell response in inflammatory nodules, including genes such as Conclusion: Distinct molecular signatures specific for each lesion type were identified, which may reflect differences in molecular mechanisms. These findings underscore the importance of distinguishing between lesion types in translational and clinical studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.